Skip to content

    FABTECH

    FABTECH
    Healthcare·28 Apr 2026
    Management Summary

    Fabtech Technologies Limited delivered a strong Q4 and FY26 performance, with significant growth in total income and EBITDA, driven by strategic transformation and global expansion. The company's balance sheet was strengthened by an equity infusion and debt reduction. While geopolitical challenges impacted margins and receivables increased, management is focused on operational discipline and projects continued growth and margin improvement for FY27, supported by a robust order book.

    Highlights

    5

    • Total income for FY26 grew by 28.4% year on year to 431.33 crore, demonstrating strong top-line growth.

    • EBITDA increased by 18.29% to 55.56 crores for FY26, reflecting operational efficiency.

    • Operational PAT for FY26 increased by 17.4% to 36.6 crores, indicating core business profitability.

    • Cash and bank balance rose sharply to 208.57 crore, and total equity expanded to 419.77 crore, strengthening the financial position.

    • Order book stands at over 900 crores as of March 31, 2026, providing strong revenue visibility for the next 18-24 months.

    Concerns

    3

    • Receivables have risen to 204.34 crore, making receivable management a strategic operational priority.

    • Margins were impacted by increased execution costs, higher RMC, and global geopolitical disruptions, despite revenue growth.

    • The company faced challenges in deploying 50 crores of working capital due to monitoring agency restrictions, now being addressed.

    Key financials

    Metrics

    10

    Periods

    3

    Headline

    3
    • Cash and Bank Balance
      ₹208.57 Cr
    • Total Equity
      ₹419.77 Cr
    • Receivables
      ₹204.34 Cr

    Q4 FY26

    2
    • Total Income
      ₹168.24 Cr
      YoY+22%
    • Net Profit
      ₹22.06 Cr

    FY26

    5
    • Total Income
      ₹431.33 Cr
      YoY+28.4%
    • EBITDA
      ₹55.56 Cr
      YoY+18.3%
    • Operational PAT
      ₹36.6 Cr
      YoY+17.4%
    • Total Net Profit
      ₹38.36 Cr
    • Other Income
      ₹21 Cr

    Order Book

    high confidence

    Total Value

    ₹ 900 crores

    as of 2026-03-31

    quantified

    Execution

    deliver in next 18 to 24 months

    Composition

    UAE(geography)
    Saudi Arabia(geography)
    Iraq(geography)
    Kenya(geography)
    Other parts of Africa(geography)
    Northern Africa (Algeria, Morocco, Egypt, Ethiopia)(geography)

    Pipeline

    deal pipeline tcv

    hot lead pipeline with offers in the market

    "Management highlighted strong revenue visibility from the order book and improved conversion rates from the hot lead pipeline."

    Source:
    Prepared remarks

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    M&A

    JBN acquisition in the West

    acquisition · pending regulatory

    Liquidity

    Cash ₹208.57 crores

    Strong liquidity position maintained despite focus on cash and collection.

    Guidance & targets

    8
    CategoryTargetPriority
    Revenue
    Revenue Growth
    approximately 25%
    		High
    Profitability
    PAT Margin
    9.9% to 10.5%
    		High
    Profitability
    EBITDA Margin
    13 to 14%
    		High
    Profitability
    PAT Margin
    9 to 11%
    		High
    Profitability
    PAT Guidance
    12 to 14%
    		High
    Order Book
    Order Book Growth (conversion/inflow)
    25 to 30%
    		Medium
    Margin
    RMC as a percentage of sales
    44 to 46 percent
    		High
    Margin
    Contribution Margin
    around 45 percent
    		High

    PAT Margin Improvement

    FY27
    Current8.48% (36.6 crores / 431.33 crores for FY26)
    Target9.9% to 10.5% range

    Why it matters

    This is a key profitability target for FY27, indicating the effectiveness of operational discipline and cost efficiencies.

    Based on current momentum, we are projecting approximately 25% growth ahead, alongside an improvement in PAT margin towards 9.9% to 10.5% range.

    How to verify

    key_financials.metrics[label='PAT Margin']

    Risks & concerns

    4
    RiskSeverity

    Geopolitical Disruptions and Supply Chain Volatility

    Global geopolitical tensions, regional conflicts, and supply chain disruptions impacted freight economics and execution costs, particularly in Q4 FY26. — Management acknowledged

    high

    High Receivables

    Receivables have risen to 204.34 crore, making collection a strategic operational priority to ensure healthy working capital cycle. — Management acknowledged

    medium

    Currency Devaluation in Emerging Markets

    Operating in pharmaceutical emerging markets exposes the company to currency devaluation, mitigated by billing in USD. — Management acknowledged

    low

    Client-Side Civil Infrastructure Readiness Impacting Project Timelines

    Order conversion timelines are variable due to client-side civil infrastructure readiness, which impacts the company's execution schedule. — Management acknowledged

    medium

    Q&A highlights

    8

    “I would say firstly, in terms of balancing the order book, while we were exposed or concentrated in the Middle East as of last year, there is a lot of positive balance that has come in the order pipeline from Africa and other markets which have not been impacted with the war currently in the Middle East. With the scenario in the Middle East, be it Saudi Arabia, be it the projects ongoing in Iraq or in UAE, there has been a turbulent environment where our focus has been more on ensuring that we stand by our clients with the ongoing deliveries and installation commissioning ongoing.”

    Analysts probed on the impact of geopolitical tensions on current and future profitability, and management detailed mitigation strategies including diversification and localization.

    asked by Darshil Zaveri

    2 min read5 chapters

    Detailed Narrative

    01

    FY26 Performance and Strategic Transformation

    Fabtech Technologies Limited reported a landmark FY26, not just for its financial numbers but for structural transformation aimed at future scale. Total income grew by 28.4% year-on-year to 431.33 crores, with EBITDA increasing by 18.29% to 55.56 crores. The company focused on building foundations across operational architecture, leadership, infrastructure, market expansion, and capital allocation, aligning for a multi-year growth cycle. This preparedness is expected to drive operating leverage and improve cost efficiency in the future.

    02

    Financial Strength and Capital Allocation

    The company's financial position was significantly strengthened in FY26. A strategic equity infusion of approximately ₹230 crores reset the balance sheet, leading to total equity expanding to 419.77 crores. Cash and bank balance rose sharply to 208.57 crores, making it the strongest financial position in Fabtech's history. Debt was reduced from 54 crores to 42 crores, and the company achieved positive operating cash flow. IPO funds are being strategically deployed for internal capability, talent acquisition, and due diligence for a JBN acquisition in the West.

    03

    Global Expansion and Localization Strategy

    Fabtech operates as an international brand across 60+ major geographies, with global business anchored by UAE and Saudi Arabia. The company's expansion in Kenya has shown strong momentum, reinforcing Africa as a powerful long-term corridor. Localization in regions like Saudi Arabia is viewed as a strategic necessity, driving trust, execution, capacity, and access. This strategy has enabled the company to secure multiple projects in the Middle East, North Africa, and other African regions, strengthening local pharmaceutical production capabilities.

    04

    Operational Discipline and Margin Management

    Operational discipline has sharpened, with a focus on cash and collection, especially as receivables rose to 204.34 crores. Despite global macroeconomic pressures, including geopolitical disruptions and supply chain challenges, the company maintained client commitments. While margins were impacted by increased execution costs (up 43%) and RMC (up 33%), management uses variation clauses in contracts and a relationship-based approach to mitigate these impacts, billing in USD to offset currency risks.

    05

    Order Book and Future Outlook

    The company's order book stands strong at over 900 crores as of March 31, 2026, providing revenue visibility for 18-24 months. A 'hot lead' pipeline of approximately 200 million USD is currently being pursued, with order conversion rates improving from 11% to a target of 16-17%. For FY27, management projects approximately 25% revenue growth and an improvement in PAT margin to a range of 9.9% to 10.5%. The company is also on track for its FY28 PAT guidance of 12% to 14%.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.